26-Mar-2020 | Facts and Factors
The global digital dose inhaler market in 2019 was approximately USD 1.70 Billion. The market is expected to grow above a CAGR of 14.3% and is anticipated to reach over USD 4.20 Billion by 2026.
An inhaler is a clinical gadget that conveys medicine into the body by means of the lungs. These inhalers are additionally called pumps, allergy sprays, or puffers. Inhalers are broadly utilized for treatment and medicine conveyance for respiratory disease, for example, constant obstructive pneumonic disease and asthma. Inhalers decrease medicine affidavit in the throat or mouth and furthermore limit the requirement for accurate synchronization with the invitation of the gadget. Advanced inhalers are outfitted with worked-in sensors that help in following utilization of inhalers, portion the executives, and portion consistency.
Browse the full “Digital Dose Inhaler Market By Product (Dry Powder Inhalers (DPIs) and Metered Dose Inhalers (MDIs)); by Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Other Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026" https://www.fnfresearch.com/digital-dose-inhaler-market-by-product-dry-powder-942
The interest in the digital dose inhaler market is driven by expanding pervasiveness of ceaseless respiratory infections, for example, asthma, and COPD, and related decline in the personal satisfaction of patients. Expanding geriatric populace over the world, expanding inclination and appropriation of advanced gadgets, expanding R&D speculation for technological improvement and gadget scaling down, developing need to accomplish medicine consistency, enhancement inpatient care, and dose tracking are other significant components that support the market development. However, the significant expense of advanced portion inhalers may confine the market development over the figure time frame. Reconciliation of AI for digital dose tracking and consistency is relied upon to bring new open doors for significant market players working in the worldwide digital dose inhaler alongside development opportunities in developing markets.
The global digital dose inhaler market has been segmented on the basis of product, and application. On the basis of the product segment, the target market is segmented into powder inhalers, and metered dose inhalers. Owing to major developments such as automated pharmacokinetic / pharmacodynamics simulation, electronic tracking devices with patient reviews, and managed release of formulations, the metered dose inhalers product category accounted for about two-thirds of the market share in 2019. A segment of the drug form of dry powder inhalers is projected to experience swift CAGR over the forecast era.
On the basis of the application segment, the global market is segmented into chronic obstructive pulmonary disease, asthma, and other applications. The asthma application fragment represented the biggest piece of the pie in 2019 while the chronic obstructive pulmonary disease class will see consistent development over the figure time frame. Expanding asthma predominance around the world has added to the wide market share.
Geographically market is categorized as Latin America, North America, APAC, Europe, and the MEA regions. North America is estimated to dominate the global market in the near future owing to the increasing adoption of technically advanced products in the countries of this region. This growth is attributed due to rising awareness among individuals regarding the use of advanced healthcare gadgets in the region.
Top key players operating in the market are GlaxoSmithKline plc., Teva Pharmaceuticals Industries Ltd, Propeller Health, Philips Respironics, Opko Health Inc., Novartis AG, Glenmark Pharmaceuticals Ltd., Cipla, Inc, AstraZeneca Plc, and AptarGroup, Inc. Key operating players of the digital dose inhaler market are focusing on the development of more advanced, reliable, and cost-effective products in order to contribute to the revenue growth of the global market.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 1.70 Billion |
Projected Market Size in 2026 |
USD 4.20 Billion |
CAGR Growth Rate |
14.3% CAGR |
Base Year |
2020 |
Forecast Years |
2020-2026 |
Key Market Players |
GlaxoSmithKline plc., Teva Pharmaceuticals Industries Ltd, Propeller Health, Philips Respironics, Opko Health Inc., Novartis AG, Glenmark Pharmaceuticals Ltd., Cipla, Inc, AstraZeneca Plc, and AptarGroup, Inc. |
Key Segment |
By Product, By Application, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
This report segments the digital dose inhaler market as follows:
Global Digital Dose Inhaler Market: Product Segmentation Analysis
- Dry Powder Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
Global Digital Dose Inhaler Market: Application Segmentation Analysis
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Other Applications
Global Digital dose inhaler Market: Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction in our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
